Latest Articles

Publication Date
Neurobiological Signatures of Endometriosis: Characterizing Pain, Cognition, and Brain Morphology.

Endometriosis affects approximately 10% of reproductive-age women worldwide and is associated with substantial pain and mental health burden, yet its neurobiological correlates remain poorly characterized. Neuroimaging studies of endometriosis are …

Published: Jan. 6, 2026, midnight
Evidence for KISS-1 nuclear translocation and PI3K/AKT signaling in the ultrastructurally and morphometrically analyzed human endometriosis.

Endometriosis is a common estrogen-dependent disease marked by ectopic endometrial growth. Although the PI3K/AKT and kisspeptin pathways are known to regulate endometrial homeostasis, their interplay in disease progression remains unclear. …

Published: Jan. 6, 2026, midnight
Artificial Intelligence in Gynecologic Imaging.

What was done? A review of artificial intelligence (AI) applications for the imaging of uterine fibroids, endometriosis, and adenomyosis. What was found? AI models can assist with the recognition, segmentation, …

Published: Jan. 6, 2026, midnight
Study Explores Role of Fibrosis in Impaired Ovarian Function and Potential Use of Pirfenidone for Endometriosis Treatment - geneonline.com

Study Explores Role of Fibrosis in Impaired Ovarian Function and Potential Use of Pirfenidone for Endometriosis Treatment geneonline.com

Published: Jan. 5, 2026, 9:43 p.m.
Menopause and endometriosis are among the conditions the NHS’s new ‘online hospital’ will focus on - Stylist

Menopause and endometriosis are among the conditions the NHS’s new ‘online hospital’ will focus on Stylist

Published: Jan. 5, 2026, 9:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - BIOENGINEER.ORG

Pirfenidone’s Promise for Ovarian Endometriosis Treatment BIOENGINEER.ORG

Published: Jan. 5, 2026, 8:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - Bioengineer.org

Pirfenidone’s Promise for Ovarian Endometriosis Treatment Bioengineer.org

Published: Jan. 5, 2026, 8:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - bioengineer.org

Pirfenidone’s Promise for Ovarian Endometriosis Treatment bioengineer.org

Published: Jan. 5, 2026, 8:34 p.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology

Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology

Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology

Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology

Published: Jan. 5, 2026, 1:12 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!